Michelle Miller - Biotron Ltd CEO, Managing Director, Executive Director

<div class='logoBackup' style='background:#FCD202;color: white;font-size:3em;;'>BIT</div>
BITRF -- USA Stock  

USD 0.041  0.004  10.81%

  CEO
Dr. Michelle Miller, BSc, MSc, Ph.D., GCertAppFin, was Chief Executive Officer, Managing Director and Executive Director of Biotron Ltd since June 21, 2002. Dr Miller has worked for over 20 years in the bioscience industry, with experience in managing commercial bioscience research. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of cancer development. Her experience includes a number of years at Johnson Johnson developing antiHIV gene therapeutics through preclinical research to clinical trials. She has experience in early stage startups from time spent as Investment Manager with a specialist bioscience VC fund.
  CEO Since 2002      
61 2 9805 0488  http://www.biotron.com.au

Michelle Miller Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (28.44) % which means that it has lost $28.44 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (47.97) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Found 9 records

CEO Since

Lars JoergensenNovo Nordisk AS
2017
Ludwig HantsonAlexion Pharmaceuticals
2017
Lars SoerensenNovo Nordisk AS
2015
Paul PerreaultCSL
2013
Xiaoyang XuSINO BIOPHARMACEUTICAL
2009
John MaraganoreAlnylam Pharmaceuticals
2007
Leonard SchleiferRegeneron Pharmaceuticals
1994
David HallalAlexion Pharmaceuticals
2015
Leonard BellAlexion Pharmaceuticals
2015

Entity Summary

Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Ltd operates under Biotechnology classification in USA and is traded on BATS Exchange.Biotron Ltd Ord [BITRF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Biotron Ltd Ord Leadership Team

Robert Thomas, Independent Non-Executive Director
Peter Nightingale, Company Secretary
Michael Hoy, Independent Non-Executive Chairman of the Board
Michelle Miller, CEO, Managing Director, Executive Director
Stephen Locarnini, Director
Denis Wade, Independent Non-Executive Director
Susan Pond, Independent Non-Executive Director

Stock Performance Indicators

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Biotron Ltd Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Biotron Ltd and Alnylam Pharmaceuticals. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.